第86回日本血液学会学術集会が、2024/10/11-13の日程にて京都国際フォーラムで開催され、CML-CSGより5演題を口説として報告しました。抄録などの詳細は、それぞれの発表をクリックしてください。
★ O1-17C-6
Novel parameters for predicting optimal response in CML treatment
○ Kohjin Suzuki, Tomoiku Takaku, Naoki Watanabe, Noriyoshi Iriyama, Eisaku Iwanaga, Yuta Kimura, Maho Ishikawa, Hitomi Nakayama, Eriko Sato, Takayuki Tabayashi Toru Mitsumori, Tomonori Nakazato, Michihide Tokuhira, Hiroyuki Fujita, Miki Ando, Yoshihiro Hatta, Tatsuya Kawaguchi.
★ O1-17D-1
Real-world data of ponatinib administration among the patients with CML-CP based on CML-CSG database
○ Masahiro Akimoto, Michihide Tokuhira Eisaku Iwanaga, Noriyoshi Iriyama, Yuta Kimura, Naoki Watanabe, Maho Ishikawa, Hitomi Nakayama, Tomonori Nakazato, Eriko Sato，Takayuki Tabayashi, Toru Mitsumori, Tomoiku Takaku, Hiroyuki Fujita, Miki Ando, Tatsuya Kawaguchi.
★O3-16B-1
Outcomes of chronic myeloid leukemia patients with impaired renal function
○ Eisaku Iwanaga, Noriyoshi Iriyama, Yuta Kimura, Naoki Watanabe, Maho Ishikawa, Hitomi Nakayama, Tomonori Nakazato, Eriko Sato, Takayuki Tabayashi, Toru Mitsumori, Tomoiku Takaku, Michihide Tokuhira, Masahiro Akimoto, Hiroyuki Fujita, Miki Ando, Tatsuya Kawaguchi.
★ O3-16B-4
Analysis of very elderly patients (=>75 years) with ND-CML-CP who received TKIs
○ Michihide Tokuhira, Yuta Kimura, Noriyoshi Iriyama, Naoki Watanabe, Maho Ishikawa, Hitomi Nakayama, Tomonori Nakazato, Eriko Sato, Takayuki Tabayashi, Toru Mitsumori, Masahiro Akimoto, Hiroyuki Fujita, Tomoiku Takaku, Miki Ando, Eisaku Iwanaga, Tatsuya Kawaguchi.
★O3-16B-5
Improvement of diabetes mellitus by dasatinib in patients with CML: a report from CML-CSG
○ Toru Mitsumori, Noriyoshi Iriyama, Tomonori Nakazato, Naoki Watanabe, Tomoiku Takaku, Maho Ishikawa, Hiroyuki Fujita, Eisaku Iwanaga, Michihide Tokuhira, Eriko Sato, Takayuki Tabayashi, Yuta Kimura, Tatsuya Kawaguchi.
